Which of the following is India’s first intranasal vaccine approved by DCGI for primary
Which of the following is India’s first intranasal vaccine approved by DCGI for primary
immunization against COVID-19 in the 18+ age group for restricted use in an emergency
situation?
Show answerHide answer
Correct answer: (B) BBV154
Explanation
Bharat Biotech's BBV154 (later named iNCOVACC) was approved by DCGI in September 2022 as India's first intranasal COVID-19 vaccine for adults, for restricted emergency use.